BLMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bloomin' Brands Inc (BLMN) is not a strong buy at this moment for a beginner investor with a long-term strategy. Despite some positive catalysts like the Outback turnaround plan and slight traffic growth, the company's financial performance, technical indicators, and analyst ratings suggest caution. The stock's price has recently surged, but the lack of strong trading signals and mixed sentiment from analysts make it prudent to hold rather than buy.
The technical indicators show a mixed to bearish outlook. The MACD is negative and contracting, RSI is neutral at 46.073, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key resistance levels (Pivot: 6.327, R1: 6.892).
The company is implementing initiatives to improve steak quality, service models, and restaurant remodels, which could drive long-term growth. Freedom Capital has a Buy rating with a $10 price target.
The company faces challenges with commodity and labor inflation, increased investments, and a multi-year execution timeline for its turnaround strategy. Financial performance in Q4 2025 showed a net loss of $13.475 million, a significant YoY decline in net income (-83.04%) and EPS (-82.98%). Analysts have mixed ratings, with some lowering price targets. The stock is also expected to decline in the short term based on historical patterns.
In Q4 2025, revenue increased by 63.21% YoY to $975.22 million, but the company reported a net loss of $13.475 million, down 83.04% YoY. EPS dropped to -0.16, down 82.98% YoY. Gross margin also declined to 65.67, down 6.80% YoY. These figures highlight ongoing challenges in profitability despite revenue growth.
Analysts have mixed ratings. Citi raised the price target to $7 but maintained a Neutral rating. Goldman Sachs lowered the price target to $6 and also kept a Neutral rating, citing challenges in the turnaround strategy. BofA lowered the price target to $5 with an Underperform rating. Freedom Capital initiated coverage with a Buy rating and a $10 price target, citing potential for long-term growth.
